Cancer Stem Cell Assay Directed Chemotherapy in Recurrent Platinum Resistant Ovarian Cancer
Phase 3
Active, not recruiting
- Conditions
- Recurrent Ovarian CarcinomaPlatinum-resistant Ovarian Cancer
- Interventions
- Diagnostic Test: ChemoID AssayDrug: Standard Chemotherapy
- First Posted Date
- 2019-05-14
- Last Posted Date
- 2024-08-22
- Lead Sponsor
- Cordgenics, LLC
- Target Recruit Count
- 150
- Registration Number
- NCT03949283
- Locations
- ๐บ๐ธ
Edwards Comprehensive Cancer Center - Cabell Huntington Hospital, Huntington, West Virginia, United States
๐บ๐ธCharleston Area Medical Center (CAMC), Charleston, West Virginia, United States
๐บ๐ธKaiser Permanente, Los Angeles, California, United States
Avastin Plus Chemotherapy vs. Avastin Plus Chemotherapy Guided by Cancer Stem Cell Test in Recurrent Ovarian Cancer
Phase 3
Withdrawn
- Conditions
- Recurrent Ovarian Cancer
- Interventions
- Diagnostic Test: ChemoID assayDrug: Chemotherapy
- First Posted Date
- 2018-08-15
- Last Posted Date
- 2025-02-12
- Lead Sponsor
- Cordgenics, LLC
- Target Recruit Count
- 300
- Registration Number
- NCT03632798
- Locations
- ๐บ๐ธ
Univeristy of Mississippi Medical Center, Jackson, Mississippi, United States
๐บ๐ธCharleston Area Medical Center, Charleston, West Virginia, United States
๐บ๐ธEdwards Comprehensive Cancer Center - Cabell Huntington Hospital, Huntington, West Virginia, United States
Standard Chemotherapy vs. Chemotherapy Guided by Cancer Stem Cell Test in Recurrent Glioblastoma
Phase 3
Completed
- Conditions
- Recurrent Glioblastoma
- Interventions
- Diagnostic Test: ChemoID assayDrug: Chemotherapy
- First Posted Date
- 2018-08-15
- Last Posted Date
- 2025-04-15
- Lead Sponsor
- Cordgenics, LLC
- Target Recruit Count
- 78
- Registration Number
- NCT03632135
- Locations
- ๐บ๐ธ
University of Mississippi Medical Center, Jackson, Mississippi, United States
๐บ๐ธToledo University, Toledo, Ohio, United States
๐บ๐ธThe Penn State Univeristy College of Medicine, Hershey, Pennsylvania, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath